SPI Medical Imaging: Tempus IPO Signals an Acceleration in the Data Race

In June, Tempus AI, Inc. completed its initial public offering on the Nasdaq Global Select Market, raising $410.7 million.

Why we have chosen this topic

• Tempus is a digital precision medicine company with a unique position in the healthtech market and role in imaging IT.
• This success poses questions about the direction of the company’s longer-term strategy and influence on the wider imaging ecosystem.

Why it matters

• The IPO indicates that competition in the clinical real-world data (cRWD) platform market is about to intensify.
• As Tempus also provides healthcare technology products like radiology AI and clinical pathway software, this news may also impact wider healthcare technology markets.